1Boynton CS,et al. NSAIDs: an overview. J Clin Pharmacol, 1988,28:512.
2Hess E V, et al. A rational approach to NSAID therapy. Ration Drug Ther,1986,20(6):1.
3Sahno JA. Role of arachidonic acid metabolites inflammatory and thrombotic, responses. Biochem Soc Trans, 1987,15:324.
4Vaananen PM ,et al. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy. Inflammation, 1992,16 (3) :227.
8Dingle JT, el al. Effect of tenidap on cartilage integrity in vitro. Ann Rheum Dis, 1993,52 (4) :292.
9Toshiaki Nishihata, Simple formulation of sustained release tablets of sodium diclofenac and examination in humans. Int J Pharm, 1987,40:125.
10Nakagaw T. et al. Chem and Pharm Rull,2002,35 (3) : 1201.
二级参考文献3
1Dr. H. Shirota,M. Goto,R. Hashida,I. Yamatsu,K. Katayama. Inhibitory effects of E-5110 on interleukin-1 generation from human monocytes[J] 1989,Agents and Actions(3-4):322～324
2George G. I. Moore,Karl F. Swingle. 2,6-Di-tert-butyl-4-(2′-thenoyl)phenol(R-830): A novel nonsteroidal anti-inflammatory agent with antioxidant properties[J] 1982,Agents and Actions(5):674～683
3E. Bramm,L. Binderup,E. Arrigoni-Martelli. An unusual profile of activity of a new basic anti-inflammatory drug, timegadine[J] 1981,Agents and Actions(4):402～409
